Dr. John Leahy, MD
What this data tells you about Dr. Leahy
Dr. John Leahy is a radiation oncology in Austin, TX, with 20 years in practice. Based on federal Medicare data, Dr. Leahy performed 17,228 Medicare services across 1,819 unique beneficiaries.
Between the years covered by Open Payments, Dr. Leahy received a total of $3,095 from 8 pharmaceutical and/or device companies across 26 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Leahy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie | 6,600 | $194 | $497 |
| Contrast dye for imaging (iodine-based) | 6,395 | $0 | $1 |
| MRI contrast dye injection (gadobutrol) | 1,980 | $0 | $1 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 514 | $631 | $2,171 |
| Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | 400 | $773 | $2,679 |
| Chest X-ray, 1 view | 240 | $7 | $137 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 149 | $89 | $380 |
| Gallium ga-68, dotatate, diagnostic, 0.1 millicurie | 120 | $314 | $964 |
| Piflufolastat f-18, diagnostic, 1 millicurie | 91 | $467 | $1,679 |
| Nuclear medicine study whole body with ct scan | 82 | $477 | $1,791 |
| Blood creatinine level | 74 | $5 | $21 |
| CT scan of abdomen and pelvis with contrast | 68 | $156 | $820 |
| Ct scan of chest with contrast | 62 | $61 | $334 |
| Radioactive drug therapy through a vein | 38 | $122 | $629 |
| Ct scan of blood vessels of chest with contrast | 37 | $66 | $1,316 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 33 | $37 | $138 |
| Nuclear medicine study of lung ventilation and circulation | 29 | $38 | $694 |
| Nuclear medicine study of bone and/or joint whole body | 28 | $199 | $657 |
| Chest X-ray, 2 views | 27 | $8 | $162 |
| CT scan of chest, without contrast | 25 | $54 | $237 |
| X-ray of abdomen, 1 view | 24 | $7 | $125 |
| Shoulder X-ray, 2+ views | 22 | $7 | $133 |
| Ultrasound scan of head and neck soft tissue | 20 | $80 | $254 |
| Nuclear medicine study of parathyroid with spect and ct scan | 19 | $330 | $1,749 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 19 | $25 | $98 |
| Ct scan of abdomen and pelvis without contrast | 18 | $85 | $611 |
| Injection, furosemide, up to 20 mg | 18 | $0 | $7 |
| Complete ultrasound scan of abdomen | 17 | $67 | $276 |
| Bone density scan (DEXA) | 17 | $36 | $209 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 16 | $17 | $418 |
| Limited ultrasound scan of abdomen | 12 | $20 | $382 |
| Nuclear medicine study of liver and bile duct system | 12 | $27 | $526 |
| X-ray of lower and sacral spine, 2-3 views | 11 | $8 | $147 |
| Hip X-ray, 2-3 views | 11 | $8 | $212 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (66%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in radiation oncology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Leahy is a mixed practice specialist, with above-average Medicare volume (top 4% in TX), and high industry engagement (speaking/promotional, top 16%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Leahy experienced with lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie?
Does Dr. Leahy receive payments from pharmaceutical companies?
How do Dr. Leahy's costs compare to other radiation oncologys in Austin?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology